Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamdouh Skafi

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Expert Opinion on Pharmacotherapy|January 5, 2019
Lenalidomide for the treatment of mantle cell lymphomaFortunato Morabito, Mamdouh Skafi, Anna Grazia Recchia, et al.
European Journal of Haematology|December 26, 2025
Chemotherapy-Sparing Strategies in Follicular Lymphoma: Emerging Targeted and Immune-Based ApproachesEnrica Antonia Martino, Santino Caserta, Mamdouh Skafi, et al.
European Journal of Haematology|February 6, 2026
Targeting Ikaros and Aiolos: Next-Generation Cereblon E3 Ligase Modulators in MMMaria Eugenia Alvaro, Enrica Antonia Martino, Santino Caserta, et al.
British Journal of Haematology|June 15, 2026
Minimal residual disease in diffuse large B-cell lymphoma after first-line therapy: Defining the continuum from metabolic remission to molecular clearanceSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
European Journal of Haematology|April 2, 2026
Targeting the Menin-KMT2A Axis in Acute Leukemia: From Epigenetic Dependency to Clinical TranslationAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
Antibiotics (Basel, Switzerland)|April 27, 2026
Gut Microbiota and Acute Myeloid Leukemia: State of the Art, Clinical Signals, and Translational OpportunitiesMaria Eugenia Alvaro, Santino Caserta, Enrica Antonia Martino, et al.
European Journal of Haematology|March 18, 2026
Elranatamab in Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Emerging PerspectivesMaria Eugenia Alvaro, Enrica Antonia Martino, Santino Caserta, et al.
European Journal of Haematology|December 26, 2025
Beyond PD-1: Mechanisms of Resistance to Checkpoint Blockade in Classical Hodgkin Lymphoma and Next-Generation Immune StrategiesSantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
European Journal of Haematology|February 3, 2026
Frontline Therapy in Diffuse Large B-Cell Lymphoma: Evolving Standards, Biological Insights, and Future DirectionsMamdouh Skafi, Santino Caserta, Ernesto Vigna, et al.
Clinical and Translational Medicine|March 7, 2026
Clonal haematopoiesis in chronic lymphocytic leukaemia: Biology, inflammaging and clinical implications in the era of targeted therapyEnrica Antonia Martino, Santino Caserta, Mamdouh Skafi, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Expert Opinion on Pharmacotherapy|January 5, 2019
Lenalidomide for the treatment of mantle cell lymphomaFortunato Morabito, Mamdouh Skafi, Anna Grazia Recchia, et al.
European Journal of Haematology|December 26, 2025
Chemotherapy-Sparing Strategies in Follicular Lymphoma: Emerging Targeted and Immune-Based ApproachesEnrica Antonia Martino, Santino Caserta, Mamdouh Skafi, et al.
European Journal of Haematology|February 6, 2026
Targeting Ikaros and Aiolos: Next-Generation Cereblon E3 Ligase Modulators in MMMaria Eugenia Alvaro, Enrica Antonia Martino, Santino Caserta, et al.
British Journal of Haematology|June 15, 2026
Minimal residual disease in diffuse large B-cell lymphoma after first-line therapy: Defining the continuum from metabolic remission to molecular clearanceSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
European Journal of Haematology|April 2, 2026
Targeting the Menin-KMT2A Axis in Acute Leukemia: From Epigenetic Dependency to Clinical TranslationAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
Antibiotics (Basel, Switzerland)|April 27, 2026
Gut Microbiota and Acute Myeloid Leukemia: State of the Art, Clinical Signals, and Translational OpportunitiesMaria Eugenia Alvaro, Santino Caserta, Enrica Antonia Martino, et al.
European Journal of Haematology|March 18, 2026
Elranatamab in Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Emerging PerspectivesMaria Eugenia Alvaro, Enrica Antonia Martino, Santino Caserta, et al.
European Journal of Haematology|December 26, 2025
Beyond PD-1: Mechanisms of Resistance to Checkpoint Blockade in Classical Hodgkin Lymphoma and Next-Generation Immune StrategiesSantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
European Journal of Haematology|February 3, 2026
Frontline Therapy in Diffuse Large B-Cell Lymphoma: Evolving Standards, Biological Insights, and Future DirectionsMamdouh Skafi, Santino Caserta, Ernesto Vigna, et al.
Clinical and Translational Medicine|March 7, 2026
Clonal haematopoiesis in chronic lymphocytic leukaemia: Biology, inflammaging and clinical implications in the era of targeted therapyEnrica Antonia Martino, Santino Caserta, Mamdouh Skafi, et al.
Pageof 2